Authors:
Buysschaert, M
Vandenbroucke, C
Barsoum, S
Citation: M. Buysschaert et al., A type 2 diabetes screening program by general practioners in a Belgian atrisk population, DIABETE MET, 27(2), 2001, pp. 109-114
Authors:
Romedenne, P
Mukendi, R
Stasse, P
Indekeu, P
Buysschaert, M
Colin, IM
Citation: P. Romedenne et al., An unusual neuropathy in a diabetic patient: evidence for intravenous immunoglobin-induced effective therapy, DIABETE MET, 27(2), 2001, pp. 155-158
Citation: M. Buysschaert et Mp. Hermans, Hyperhomocysteinemia and macroangiopathy in type 2 diabetes - Response, DIABET CARE, 24(6), 2001, pp. 1124-1125
Citation: S. Deckers et al., Therapy, glycaemic control and complications in type 1 diabetic patients: Results from a single centre cohort of 465 subjects, ACT CLIN B, 56(5), 2001, pp. 289-296
Authors:
Dysseleer, A
Buysschaert, M
Fonck, C
Deuren, KV
Jadoul, M
Tennstedt, D
Cosyns, JP
Daumerie, C
Citation: A. Dysseleer et al., Acute interstitial nephritis and fatal Stevens-Johnson syndrome after propylthiouracil therapy, THYROID, 10(8), 2000, pp. 713-716
Authors:
Buysschaert, M
Wallemacq, PE
Dramais, AS
Hermans, MP
Citation: M. Buysschaert et al., Hyperhomocysteinemia in type 2 diabetes - Relationship to macroangiopathy,nephropathy, and insulin resistance, DIABET CARE, 23(12), 2000, pp. 1816-1822
Authors:
Buysschaert, M
Bobbioni, E
Starkie, M
Frith, L
Van Gaal, L
Somers, G
Reynders, P
Buysschaert, M
Bouillon, R
Johansen, J
Gilehuus, RE
Furuseth, K
Hansen, AN
Luhdbo, C
Caldeira, J
Saraiva, M
Correa, N
Medina, L
Silva, JL
Robertson, L
Lourens, W
Bonnici, F
Distiller, L
Ellis, G
Gomez, F
Golay, A
Suter, S
Harrower, ADB
Rayman, G
Shaw, I
Simpson, HCR
Johnston, C
White, M
Hepburn, DA
Beer, SF
Leatherdale, BA
Coppack, S
Hamill, JJ
Fisher, BM
Citation: M. Buysschaert et al., Troglitazone in combination with sulphonylurea improves glycaemic control in Type 2 diabetic patients inadequately controlled by sulphonylurea therapy alone, DIABET MED, 16(2), 1999, pp. 147-153
Citation: M. Buysschaert et Mp. Hermans, Glycaemic and blood pressure controls achieved in a cohort of 318 patientswith type 2 diabetes, ACT CLIN B, 54(6), 1999, pp. 328-333
Authors:
Bex, M
Buysschaert, M
De Leeuw, I
De Schepper, J
Fery, F
Hermans, MP
Keymeulen, B
Lauvaux, JP
Letiexhe, M
Mathieu, C
Nobels, FR
Rottiers, R
Scheen, A
Schmitt, H
Van Crombrugge, P
Van Gaal, L
Citation: M. Bex et al., Insulin lispro (Humalog((R))) in the treatment of diabetes mellitus: Overview of Belgian clinical data from global studies, ACT CLIN B, 54(5), 1999, pp. 241-245